Haichun Huang's profile

Haichun Huang

Researcher

Novarock biotherapeutics

I'm working on

3 years ago

Expertise in Ab discovery and devel. A coinventor of 30+ patents.

About

We have functional antibodies against the following targets: 1. Anti-IL-23p19 2. Anti-IL-23p40 3. Anti-IL-8 4. Anti-IL-4Ra 5. Anti-TSLP 6. Anti-PD1 7. Anti-PDL-1 8. Anti-IL25 Please contact me if you are interested in any of these Abs.

Partnering listings

Learn more

Novarock biotherapeutics

NBL-012 monoclonal antibody targeting il23p19 for chronic skin inflammatory diseases

NBL-012 is a novel monoclonal antibody that inhibits IL23p19 binding to IL23R, addressing chronic skin inflammatory conditions such as psoriasis and hidradenitis suppurativa. Phase I results demonstrate an extended half-...

TechnologyIn developmentCompany

Haichun Huang

Researcher

Novarock biotherapeutics

Work experience

Novarock biotherapeutics

Researcher

2018 - Present

Top industry applications

Not enough data yet.
Results may appear later and can be imperfect.

Expertise

BiopharmaceuticsBiotechnologyCell BiologyDrug DeliveryImmunohistochemistry

Last updated Feb 2024